Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
RS3PE presenting in a unilateral pattern: Case report and review of the literature
Seminars in Arthritis and Rheumatism, 11/24/08
Keenan RT et al. – Although remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is almost always a symmetric disease of the upper extremities, it may rarely present in a unilateral fashion, suggesting a role for neural and possibly other local factors in the genesis/modulation of the onset or maintenance of the disease.
Methods- Study to review the clinical features and pathophysiologic implications of RS3PE presenting in a unilateral manner
- An index case of unilateral RS3PE was identified and characterized
- A systematic literature search to identify other reports of pts
- Index case: 76-yr-old male, cerebrovascular accident 25 yrs prior, developed a classic picture of RS3PE accompanied by an elevated ESR, but only in the nonhemiparetic hand
- Condition responded rapidly to low-dose prednisone
- Literature search identified 5 other cases, including 2 presented only in the Italian or German literature
- 2/5 were in pts with preexisting neurologic disease, in which the neurologically affected side was spared
- 1 additional case initially presented as unilateral disease but rapidly progressed to bilaterality
- 2 cases presented in a fully unilateral manner despite no reported neurologic abnormalities on the unaffected sides
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
The beneficial effects of a 3 week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: Results of the STIVEA trial
Annals of Rheumatic Diseases, 10/23/09
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
Annals of Rheumatic Diseases, 10/12/09
Sponsor
Article Search
Sponsor


See Latest Articles


